Wall Street expects Colgate-Palmolive to report Q1 2026 revenue of $5.38 billion and EPS of $0.95, with the stock currently trading at $98.45 relative to a consensus price target of $105.50. The central narrative for this report is Organic Sales Growth, as investors look for volume-led gains to compensate for moderating price increases.
Recent performance has been bolstered by significant margin expansion and the continued strength of the Hill’s Pet Nutrition business despite broader consumer spending volatility. Analysts are particularly focused on whether the company's aggressive reinvestment in advertising is effectively defending market share in the core toothpaste and oral care categories across emerging markets.